Edward Atkinson

Directeur Technique/Scientifique/R&D chez VERTEX PHARMACEUTICALS INCORPORATED

Fortune : 12 M $ au 30/04/2024

58 ans

Health Technology

Consumer Services

Postes actifs de Edward Atkinson

Sociétés	Poste	Début	Fin
89BIO, INC.	Directeur/Membre du Conseil	17/02/2022	-
89BIO, INC.	Independent Dir/Board Member	17/02/2022	-
VERTEX PHARMACEUTICALS INCORPORATED	Directeur Technique/Scientifique/R&D	29/08/2023	-
VERTEX PHARMACEUTICALS INCORPORATED	Corporate Officer/Principal	01/07/2020	29/08/2023

Sociétés	Poste	Début	Fin
BRISTOL-MYERS SQUIBB COMPANY	Corporate Officer/Principal	01/01/2012	01/06/2020
Catalent Indiana LLC Catalent Indiana LLC Pharmaceuticals: MajorHealth Technology Catalent Indiana LLC manufactures biopharmaceutical products. It also manufactures cell culture, recovery and purification, prefilled syringe filling, vial filling and lyophilization, inspection, labeling and packaging. The company was founded in 2004 and is headquartered in Bloomington, IN.	Directeur Technique/Scientifique/R&D	01/02/2011	19/09/2012

Stanford University	Doctorate Degree
Indiana University	Undergraduate Degree

Internationale

Etats-Unis

Opérationnelle

Chief Tech/Sci/R&D Officer	2
Corporate Officer/Principal	2
Director/Board Member	1

Sectorielle

Health Technology	5
Consumer Services	3

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Sociétés cotées	3
89BIO, INC.	Health Technology
VERTEX PHARMACEUTICALS INCORPORATED	Health Technology
BRISTOL-MYERS SQUIBB COMPANY	Health Technology

Entreprise privées	1
Catalent Indiana LLC Catalent Indiana LLC Pharmaceuticals: MajorHealth Technology Catalent Indiana LLC manufactures biopharmaceutical products. It also manufactures cell culture, recovery and purification, prefilled syringe filling, vial filling and lyophilization, inspection, labeling and packaging. The company was founded in 2004 and is headquartered in Bloomington, IN.	Health Technology